VolitionRx Statistics
Total Valuation
VolitionRx has a market cap or net worth of $26.28 million. The enterprise value is $36.62 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VolitionRx has 158.48 million shares outstanding. The number of shares has increased by 23.46% in one year.
| Current Share Class | 158.48M |
| Shares Outstanding | 158.48M |
| Shares Change (YoY) | +23.46% |
| Shares Change (QoQ) | +11.80% |
| Owned by Insiders (%) | 4.94% |
| Owned by Institutions (%) | 15.19% |
| Float | 137.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.21 |
| Forward PS | 7.05 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 21.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -166.70% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 407.89% |
| Weighted Average Cost of Capital (WACC) | 13.25% |
| Revenue Per Employee | $23,032 |
| Profits Per Employee | -$311,427 |
| Employee Count | 75 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.44% in the last 52 weeks. The beta is 1.33, so VolitionRx's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -66.44% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.43 |
| Relative Strength Index (RSI) | 36.29 |
| Average Volume (20 Days) | 29,500,547 |
Short Selling Information
The latest short interest is 1.36 million, so 0.86% of the outstanding shares have been sold short.
| Short Interest | 1.36M |
| Short Previous Month | 2.29M |
| Short % of Shares Out | 0.86% |
| Short % of Float | 0.99% |
| Short Ratio (days to cover) | 0.85 |
Income Statement
In the last 12 months, VolitionRx had revenue of $1.73 million and -$23.36 million in losses. Loss per share was -$0.22.
| Revenue | 1.73M |
| Gross Profit | 1.73M |
| Operating Income | -21.74M |
| Pretax Income | -23.50M |
| Net Income | -23.36M |
| EBITDA | -20.75M |
| EBIT | -21.74M |
| Loss Per Share | -$0.22 |
Full Income StatementBalance Sheet
The company has $1.12 million in cash and $11.46 million in debt, with a net cash position of -$10.35 million or -$0.07 per share.
| Cash & Cash Equivalents | 1.12M |
| Total Debt | 11.46M |
| Net Cash | -10.35M |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | -35.59M |
| Book Value Per Share | -0.27 |
| Working Capital | -10.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.68 million and capital expenditures -$89,558, giving a free cash flow of -$19.77 million.
| Operating Cash Flow | -19.68M |
| Capital Expenditures | -89,558 |
| Depreciation & Amortization | 983,706 |
| Net Borrowing | 6.02M |
| Free Cash Flow | -19.77M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,258.47% |
| Pretax Margin | -1,360.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VolitionRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.46% |
| Shareholder Yield | -23.46% |
| Earnings Yield | -88.89% |
| FCF Yield | -75.25% |
Analyst Forecast
The average price target for VolitionRx is $2.00, which is 1,106.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.00 |
| Price Target Difference | 1,106.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 168.66% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VolitionRx has an Altman Z-Score of -62.41 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -62.41 |
| Piotroski F-Score | 1 |
